CorMedix CRMD took a major step to diversify its revenue base and lessen reliance on its lead marketed product, DefenCath ...

The final, formatted version of the article will be published soon. Introduction: Reperfusion injury remains a major limitation in the management of ST-segment elevation myocardial infarction (STEMI).

Introduction: Reperfusion injury remains a major limitation in the management of ST-segment elevation myocardial infarction (STEMI). Despite numerous preclinical successes, cardioprotective strategies ...

Credit: National Institute of Allergy and Infectious Diseases/NIH. A low-cost, widely available drug may offer new hope for patients with severe COVID-19. An international study led by the Australian ...

The company said these launches expand its portfolio to include 25,000 Units Heparin in 0.45% Sodium Chloride Injection and 25,000 Units Heparin in 0.45% Sodium Chloride Injection. B. Braun added this ...

BETHLEHEM, Pa., July 18, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium Injections ...

BALTIMORE - Thousands of miles from a manufacturing plant in China, where the key active ingredient in heparin is sourced, Wanda Crowell receives a daily infusion of the drug in her bed at Johns ...

Background and Aims: Previous studies indicated the usual dose heparin(5000 IU bolus followed by 500~1250 IU/h) during mechanical thrombectomy(MT) is associated with an increased risk of hemorrhagic ...